Does TALAZOPARIB Cause Anaemia? 219 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Anaemia have been filed in association with TALAZOPARIB (Talzenna). This represents 14.8% of all adverse event reports for TALAZOPARIB.
219
Reports of Anaemia with TALAZOPARIB
14.8%
of all TALAZOPARIB reports
20
Deaths
80
Hospitalizations
How Dangerous Is Anaemia From TALAZOPARIB?
Of the 219 reports, 20 (9.1%) resulted in death, 80 (36.5%) required hospitalization, and 24 (11.0%) were considered life-threatening.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALAZOPARIB. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does TALAZOPARIB Cause?
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
Nausea (53)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which TALAZOPARIB Alternatives Have Lower Anaemia Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS